Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

Impact of COVID-19 infection on hospitalization outcomes in patients with myeloproliferative neoplasms: Analysis of the national inpatient sample 2020–2021

View Full Paper
Ask AI
Bookmark
Share

Authors

EJEvani JainCSChiranjeevi SainathamPCPrashant Chaulagain

Discussion

Loading...

Member takes

Overview

Analysis reveals increased mortality odds and thromboembolic events in patients with myeloproliferative neoplasms and COVID-19.

Key Points

  • Hospitalization among MPN patients with COVID-19 was linked to significantly higher mortality rates.
  • Patients with COVID-19 had an increased risk of acute kidney injury and other organ failures.
  • Observational analysis in the National Inpatient Sample revealed 37,650 hospitalizations with MPN.
  • Heightened vigilance is warranted for this vulnerable group, given their elevated thromboembolic risk.

Cite This Study

Jain et al. (2025) studied this question.

synapsesocial.com/papers/69362f5d4fa91c937236dbebhttps://doi.org/10.1182/blood-2025-7319
View Full Paper
Ask AI
Bookmark
Share